Johnson & Johnson (JNJ)
NYSE: JNJ · IEX Real-Time Price · USD
158.19
+0.23 (0.15%)
At close: Mar 28, 2024, 4:00 PM
158.39
+0.20 (0.13%)
After-hours: Mar 28, 2024, 5:42 PM EDT
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $380.65 billion as of March 28, 2024. Its market cap has decreased by -5.02% in one year.
Market Cap
380.65B
Enterprise Value
387.05B
1-Year Change
-5.02%
Ranking
Category
Stock Price
$158.19
Market Cap Chart
Since May 14, 2001, Johnson & Johnson's market cap has increased from $136.61B to $380.65B, an increase of 178.64%. That is a compound annual growth rate of 4.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 380.49B | 1.41% |
Mar 26, 2024 | 375.21B | 0.35% |
Mar 25, 2024 | 373.89B | -0.01% |
Mar 22, 2024 | 373.91B | -0.33% |
Mar 21, 2024 | 375.17B | -0.01% |
Mar 20, 2024 | 375.19B | -0.29% |
Mar 19, 2024 | 376.27B | -0.35% |
Mar 18, 2024 | 377.60B | -0.90% |
Mar 15, 2024 | 381.02B | -0.65% |
Mar 14, 2024 | 383.50B | -1.17% |
Mar 13, 2024 | 388.05B | -1.01% |
Mar 12, 2024 | 392.00B | 0.94% |
Mar 11, 2024 | 388.37B | 1.07% |
Mar 8, 2024 | 384.25B | 0.41% |
Mar 7, 2024 | 382.68B | -0.29% |
Mar 6, 2024 | 383.81B | -0.39% |
Mar 5, 2024 | 385.33B | 0.08% |
Mar 4, 2024 | 385.02B | -1.41% |
Mar 1, 2024 | 390.51B | 0.46% |
Feb 29, 2024 | 388.73B | -0.11% |
Feb 28, 2024 | 389.14B | 0.35% |
Feb 27, 2024 | 387.76B | 0.12% |
Feb 26, 2024 | 387.31B | -0.65% |
Feb 23, 2024 | 389.83B | 0.87% |
Feb 22, 2024 | 386.49B | 1.12% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 735.08B |
Novo Nordisk | 580.33B |
UnitedHealth Group | 450.93B |
Merck & Co. | 317.37B |
AbbVie | 317.35B |
Thermo Fisher | 218.71B |
AstraZeneca | 207.09B |
Novartis AG | 196.01B |